Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic
NCT04263909Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Dec 2020
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of SurBred in postoperative pain, sponsored by Brigham and Women's Hospital. Started Dec 2020; status: completed.
02
Drugs
SurBred
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04263909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04263909.